A new three-drug combo just got FDA approval and it’s seriously shaking up treatment for relapsed follicular lymphoma. In a big trial, patients on the new mix had a nearly 80% lower risk of their cancer coming back or getting worse compared to the old standard. Over 95% saw their tumors shrink! This could be a total game-changer for anyone fighting this type of cancer. #Health #BodyHealth #LymphomaAwareness